These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10071197)

  • 1. P57 (KIP2) polymorphisms and breast cancer risk.
    Li Y; Millikan RC; Newman B; Conway K; Tse CK; Liu ET
    Hum Genet; 1999 Jan; 104(1):83-8. PubMed ID: 10071197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the human p57KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis.
    Tokino T; Urano T; Furuhata T; Matsushima M; Miyatsu T; Sasaki S; Nakamura Y
    Hum Genet; 1996 May; 97(5):625-31. PubMed ID: 8655143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
    Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
    Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
    Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
    Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of p57(KIP2) gene mutation in Beckwith-Wiedemann syndrome.
    Gaston V; Le Bouc Y; Soupre V; Vazquez MP; Gicquel C
    Horm Res; 2000; 54(1):1-5. PubMed ID: 11182628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts.
    Takahashi K; Kobayashi T; Kanayama N
    Mol Hum Reprod; 2000 Nov; 6(11):1019-25. PubMed ID: 11044465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of the p57(Kip2) gene in bone metabolism.
    Urano T; Hosoi T; Shiraki M; Toyoshima H; Ouchi Y; Inoue S
    Biochem Biophys Res Commun; 2000 Mar; 269(2):422-6. PubMed ID: 10708569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
    Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
    Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between expression of p57(kip2), cyclin E protein, PCNA, and clinicopathological factors in human pancreatic cancer].
    Yue H; Zhang N; Feng XL; Ma SR; Song FL; Yang M; Tang YH
    Ai Zheng; 2003 Jul; 22(7):705-9. PubMed ID: 12866960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer.
    Liang B; Wang S; Yang X; Ye Y; Yu Y; Cui Z
    Chin Med J (Engl); 2003 Jan; 116(1):20-3. PubMed ID: 12667381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of p27
    Kim GJ; Kim DH; Min KW; Kim YH; Oh YH
    Pathol Res Pract; 2018 Apr; 214(4):565-571. PubMed ID: 29482985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour.
    Taniguchi T; Okamoto K; Reeve AE
    Oncogene; 1997 Mar; 14(10):1201-6. PubMed ID: 9121769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal-induced ubiquitination of p57(Kip2) is independent of the C-terminal consensus Cdk phosphorylation site.
    Leibovitch MP; Kannengiesser C; Leibovitch SA
    FEBS Lett; 2003 May; 543(1-3):125-8. PubMed ID: 12753918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes.
    Li G; Domenico J; Lucas JJ; Gelfand EW
    J Immunol; 2004 Aug; 173(4):2383-91. PubMed ID: 15294951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodic expression of the cyclin-dependent kinase inhibitor p57(Kip2) in trophoblast giant cells defines a G2-like gap phase of the endocycle.
    Hattori N; Davies TC; Anson-Cartwright L; Cross JC
    Mol Biol Cell; 2000 Mar; 11(3):1037-45. PubMed ID: 10712518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy.
    Kassem SA; Ariel I; Thornton PS; Hussain K; Smith V; Lindley KJ; Aynsley-Green A; Glaser B
    Diabetes; 2001 Dec; 50(12):2763-9. PubMed ID: 11723059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of P57(kip2) and cyslinE proteins in human pancreatic cancer.
    Yue H; Yu J; Zhao X; Song F; Feng X
    Chin Med J (Engl); 2003 Jun; 116(6):944-6. PubMed ID: 12877813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent changes of p57(Kip2) and p21(Cip1/Waf1) expression in skeletal muscle and lung of mice.
    Park CW; Chung JH
    Biochim Biophys Acta; 2001 Aug; 1520(2):163-8. PubMed ID: 11513958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hallmarks of CDKN1C (p57, KIP2) in cancer.
    Kavanagh E; Joseph B
    Biochim Biophys Acta; 2011 Aug; 1816(1):50-6. PubMed ID: 21447370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human p57(KIP2) transgene is not activated by passage through the maternal mouse germline.
    John RM; Hodges M; Little P; Barton SC; Surani MA
    Hum Mol Genet; 1999 Nov; 8(12):2211-9. PubMed ID: 10545601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.